Synthesis and Comparison of In Vitro Leishmanicidal Activity of 5-(Nitroheteroaryl)-1, 3, 4-Thiadiazols Containing Cyclic Amine of Piperidin-4-ol at C-2 with Acyclic Amine Analogues against Iranian Strain of Leishmania major (MRHO/IR/75/ER)
AbstractBackground: Cutaneous Leishmaniasis (CL) is endemic in many tropical and subtropical regions of the world. Due to the prolonged duration of therapy, adverse effect and resistance to current drugs in the treatment of CL, the discovery of novel, efficient, and safe leishmanicidal drugs is required. The aims of the present study was to synthesis of new compounds based on the active compounds of 5-(5-nitrofuran-2-yl)- and 5-(5-nitrothiophen-2-yl)-1,3,4-thiadiazole bearing the linear amino alcohol of 3-aminopropan-1-ol in the C-2 position of thiadiazole ring and evaluation of their activity against the promastigote and amastigote forms of Leishmania major.Methods: Reaction between the solution of 5-(5-nitro heteroaryl)-2-chloro-1, 3, 4-thiadiazole and piperidin-4-ol in absolute ethanol was performed and the resulting products were evaluated against promastigotes form of L. major with MTT assay and amastigote form of L. major in murine peritoneal macrophages. In addition, the toxicity of these compounds was assessed against mouse peritoneal macrophages with MTT assay.Results: New synthetic compounds 5a-b showed moderate in vitro antileishmanial activity against L. major promastigotes with IC50 values of 68.9 and 27 µM, respectively. These compounds have also demonstrated a good antiamastigote activity in terms of amastigote number per macrophage, the percentage of macrophage infectivity and infectivity index.Conclusion: Novel cyclic compounds 5a-b were synthesized and exhibited less antipromastigote and antiamastigote activity compared to linear analogues.
Behrouzi-Fardmoghadam M, Poorrajab F, Ardestani SK, Emami S, Shaﬁee A, Foroumadi A (2008) Synthesis and in vitro anti-leishmanial activity of 1-[5- (5-nitrofuran-2-yl)-1,3,4-thiadiazol-2-yl]- and 1-[5-(5-nitrothiophen-2-yl)-1, 3, 4- thiadiazol-2-yl]-4-aroylpiperazines. Bioorg Med Chem. 16: 4509–4515.
CDC (2013) Centers for Disease Control and Prevention, USA.Chawla B, Madhubala R (2010) Drug targets in leishmania. J Parasit Dis. 34: 1–13.
Dutta A, Bandyopadhyay S, Mandal C, Chatterjee M (2005) Development of a modified MTT assay for screening an- timonial resistant field isolates of Indian visceral leishmaniasis. Parasitol Int. 54:119–122.
Kiderlen AF, Kaye PM (1990) A modified colorimetric assay of macrophage acti- vation for intracellular cytotoxicity against Leishmania parasites. J Immu- nol Methods. 127: 11–18.
Marznaki FR, Shakeri R, Ardestani SK, Tahghighi A, Foroumadi A (2013) In vitro immunobiological studies of novel
-(5-nitrofuran-2-yl)-1, 3, 4-thiadiazoles with piperazinyl-linked benzamidine sub- stituents against leishmania major. Iran J Allergy Asthma Immunol. 12: 368–376.
Molina R, Gradoni L, Alvar J (2003) HIV and the transmission of leishmania. Ann Trop Med Parasit. 97: S29–S45.
Monzote L (2009) Current treatment of leishmaniasis: A Review. Open Anti- microb Agents J. 1: 9–19.
Singh S, Sivakumar R (2004) Challenges and new discoveries in the treatment of leishmaniasis, J Infect Chemother. 10:307–315.
Tahghighi A, Marznaki FR, Kobarfard F, Dastmalchi S, Mojarrad JS, Razmi S, Ardestani SK, Emami S, Shafiee A, Foroumadi A (2011) Synthesis and an- tileishmanial activity of novel 5-(5-ni- trofuran-2-y1)-1,3,4-thiadiazoles with piperazinyl-linked benzamidine substit- uents. Eur J Med Chem. 46: 2602–2608.
Tahghighi A, Razmi S, Mahdavi M, Foroumadi P, Ardestani SK, Emami S, Kobarfard F, Dastmalchi S, Shafiee A, Foroumadi A (2012) Synthesis and antileishmanial activity of 5-(5-nitrofuran-2-yl)-1,3,4-thiadiazol-2-amines containing N- [(1-benzyl-1H-1,2,3-triazol-4-yl)methyl] moieties. Eur J Med Chem. 50: 124–128.
Tahghighi A, Marznaki FR, Emami S, Ar- destani SK, Dastmalchi S, Kobarfard F, Shafiee A, Foroumadi A (2013) New 5-(nitroheteroaryl)-1, 3, 4-thiadia- zols containing acyclic aminesat C-
: synthesis and SAR study for their an- tileishmanial activity. J Enzyme Inhib Med Chem. 28: 843–852.
Tanaka AK, Valero VB, Takahashi HK, Straus AH (2007) Inhibition of Leish- mania (Leishmania) amazonensis growth and infectivity by aureobasidin A. J Antimicrob Chemother. 59: 487–492.
Tiuman TS, Santos AO, Ueda-Nakamura T, Filho BP, Nakamura CV (2011) Re- cent advances in leishmaniasis treat- ment. Int J Infect Dis. 15: e525–e532.
Vosooghi M, Sabourian R, Tahghighi A, Mahdavi M, Emami S, Razmi S, Ardestani SK, Safavi M, Foroumadi P, Kaveh S, Khoshneviszadeh M, Edraki N, Shafiee A, Foroumadi A (2015) Synthesis, antileishmanial activity and QSAR study of (1, 3, 4-thiadiazol-2- ylthio) acetamides derived from 5-ni- trofuran. Med Chem Res. 24: 891–900.
WHO (2010) Control of the leishmaniases: report of a meeting of the WHO Expert Committee on the Control of Leish- maniases, Geneva, 22–26 March, 2010.